June 13th, 2017
Artificial Intelligence – drug development – NYC MedTech program
Tuesday, June 13th
at the New York offices of Troutman Sanders LLP,
Please note new address – 875 Third Avenue
Alix M. Lacoste
Data Scientist & SME, Watson Life Science Discovery
IBM is a global technology and innovation company headquartered in Armonk, NY. It is the largest technology and consulting employer in the world. IBMers are helping transform healthcare, improving the retail shopping experience, rerouting traffic jams and even designing the next generation fan experience in sports stadiums around the world.
Avanlee Okragly, Vice President
SimpleC is a science based technology company that designs and delivers media-based behavioral therapies, presented as storyboards, to engage individuals. SimpleC help people maintain a healthy daily cadence by prompting for important daily activities, improving motivation through positive reflection and, if needed, specialized behavioral support.
Neel S. Madhukar, CEO
Forbes 30 under 30
OneThree Biotech uses artificial intelligence to identify the mechanisms and downstream clinical effects of drugs in development. Target deconvolution is crucial for understanding mechanisms of action, side-effects, designing better clinical trials, and obtaining regulatory approval, however current efforts can take up to 5 years per compound. OneThree’s proprietary platform identifies drug binding targets and any corresponding side-effects with 90% accuracy in a fraction of the time. .